154 related articles for article (PubMed ID: 11378658)
21. Coagulation and metastasis: what does the experimental literature tell us?
Gil-Bernabé AM; Lucotti S; Muschel RJ
Br J Haematol; 2013 Aug; 162(4):433-41. PubMed ID: 23691951
[TBL] [Abstract][Full Text] [Related]
22. L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest.
Läubli H; Stevenson JL; Varki A; Varki NM; Borsig L
Cancer Res; 2006 Feb; 66(3):1536-42. PubMed ID: 16452210
[TBL] [Abstract][Full Text] [Related]
23. Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-Selectin.
Schwarz S; Gockel LM; Naggi A; Barash U; Gobec M; Bendas G; Schlesinger M
Molecules; 2020 Feb; 25(5):. PubMed ID: 32110917
[TBL] [Abstract][Full Text] [Related]
24. Quantification of heparin's antimetastatic effect by single-cell force spectroscopy.
Liebsch AG; Schillers H
J Mol Recognit; 2021 Jan; 34(1):e2854. PubMed ID: 32452079
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model.
Sudha T; Phillips P; Kanaan C; Linhardt RJ; Borsig L; Mousa SA
Clin Exp Metastasis; 2012 Jun; 29(5):431-9. PubMed ID: 22415710
[TBL] [Abstract][Full Text] [Related]
26. Antimetastatic activities of heparins and modified heparins. Experimental evidence.
Borsig L
Thromb Res; 2010 Apr; 125 Suppl 2():S66-71. PubMed ID: 20434009
[TBL] [Abstract][Full Text] [Related]
27. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G
Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802
[TBL] [Abstract][Full Text] [Related]
28. Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.
Kozlowski EO; Pavao MS; Borsig L
J Thromb Haemost; 2011 Sep; 9(9):1807-15. PubMed ID: 21676168
[TBL] [Abstract][Full Text] [Related]
29. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
[TBL] [Abstract][Full Text] [Related]
30. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
31. Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin.
Gao Y; Wei M; Zheng S; Ba X; Hao S; Zeng X
J Cancer Res Clin Oncol; 2006 Apr; 132(4):257-64. PubMed ID: 16331491
[TBL] [Abstract][Full Text] [Related]
32. Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets.
Becker KA; Beckmann N; Adams C; Hessler G; Kramer M; Gulbins E; Carpinteiro A
Clin Exp Metastasis; 2017 Jan; 34(1):25-35. PubMed ID: 27744579
[TBL] [Abstract][Full Text] [Related]
33. Pictures in molecular medicine: three-dimensional visualization of intravascular tumor cells in mice.
Borsig L; Wong R; Feramisco J; Nadeau DR; Varki NM; Varki A
Trends Mol Med; 2001 Aug; 7(8):377. PubMed ID: 11517000
[No Abstract] [Full Text] [Related]
34. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.
Schlesinger M; Roblek M; Ortmann K; Naggi A; Torri G; Borsig L; Bendas G
Thromb Res; 2014 May; 133(5):855-62. PubMed ID: 24636486
[TBL] [Abstract][Full Text] [Related]
35. Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines.
Monzavi-Karbassi B; Stanley JS; Hennings L; Jousheghany F; Artaud C; Shaaf S; Kieber-Emmons T
Int J Cancer; 2007 Mar; 120(6):1179-91. PubMed ID: 17154173
[TBL] [Abstract][Full Text] [Related]
36. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis.
Chen M; Geng JG
Arch Immunol Ther Exp (Warsz); 2006; 54(2):75-84. PubMed ID: 16648968
[TBL] [Abstract][Full Text] [Related]
37. Tumor interaction with hemostasis: the rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer.
Al-Mondhiry H
Am J Hematol; 1984 Feb; 16(2):193-202. PubMed ID: 6364802
[TBL] [Abstract][Full Text] [Related]
38. The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo.
Ludwig RJ; Alban S; Bistrian R; Boehncke WH; Kaufmann R; Henschler R; Gille J
Thromb Haemost; 2006 Mar; 95(3):535-40. PubMed ID: 16525583
[TBL] [Abstract][Full Text] [Related]
39. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.
Furman MI; Kereiakes DJ; Krueger LA; Mueller MN; Pieper K; Broderick TM; Schneider JF; Howard WL; Fox ML; Barnard MR; Frelinger AL; Michelson AD
Am Heart J; 2001 Nov; 142(5):790-8. PubMed ID: 11685164
[TBL] [Abstract][Full Text] [Related]
40. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
